| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/13/2013 | CN101219219B Complex containing vascellum chalone or fragment, preparation method and application thereof |
| 02/12/2013 | US8372968 RNA interference mediating small RNA molecules |
| 02/12/2013 | US8372961 Polynucleotides encoding concatameric immunoadhesion molecules |
| 02/12/2013 | US8372959 Production of recombinant proteins by autoproteolytic cleavage of a fusion protein |
| 02/12/2013 | US8372958 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram posiive bacteria |
| 02/12/2013 | US8372953 Composition comprising various proteorhodopsins and/or bacteriorhodopsins and use thereof |
| 02/12/2013 | US8372951 Cell penetrating peptides for intracellular delivery |
| 02/12/2013 | US8372948 12 human secreted proteins |
| 02/12/2013 | US8372889 Methods for modulating metabolism |
| 02/12/2013 | US8372886 Treatment of renal disorders, diabetic nephropathy and dyslipidemias |
| 02/12/2013 | US8372821 Stable aqueous compositions comprising bioactive creatine species |
| 02/12/2013 | US8372812 Phospholipid and protein tablets |
| 02/12/2013 | US8372811 Composition for treating retinopathy or glaucoma comprising thrombin derived peptides |
| 02/12/2013 | US8372810 Anti-tumor drug, medicament, composition, and use thereof |
| 02/12/2013 | US8372809 Method of treating dyspnea associated with acute heart failure |
| 02/12/2013 | US8372808 Suppression of glial fibrillary acidic protein |
| 02/12/2013 | US8372806 Apparatus comprises an ablator that is configured to generate a microporation in area of skin of patient, and comprising a drug which effects biological regulation of at least one of oocyte containing follicle, stimulation of follicle growth, induction of ovulation, promotion of gestational status |
| 02/12/2013 | US8372805 Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects |
| 02/12/2013 | US8372804 Delivery of active agents |
| 02/12/2013 | US8372802 Fluorinated macrocyclic compounds as hepatitis C virus inhibitors |
| 02/12/2013 | US8372800 Albumin-free factor VIII formulations |
| 02/12/2013 | US8372799 Reverse protein |
| 02/12/2013 | US8372798 A stable antibody liquid comprising a precipitated immunoglobulins and water; precipitating with a biocompatible polymer; storage stability |
| 02/12/2013 | US8372641 Marrow stem cell and pancreatic β cell fusion cell useful for the treatment of diabetes |
| 02/12/2013 | US8372615 Fusion proteins |
| 02/12/2013 | US8372436 Methods of producing nano-and microcapsules of spider silk proteins |
| 02/12/2013 | US8372412 Bioassay and peptides for use therein |
| 02/12/2013 | US8372409 Dendritic cell binding proteins and uses thereof |
| 02/12/2013 | US8372406 Antitumoral and antiviral peptides |
| 02/12/2013 | US8372402 Mammalian receptor proteins DCRS5; methods of treatment |
| 02/12/2013 | US8372401 Human antibodies that bind human TNFα |
| 02/12/2013 | US8372400 Methods of treating disorders using human antibodies that bind human TNFα |
| 02/12/2013 | US8372399 Bispecific antibodies and agents to enhance stem cell homing |
| 02/12/2013 | US8372397 Methods for regulation of stem cells |
| 02/12/2013 | US8372393 Method of inducing a CTL response |
| 02/12/2013 | US8372389 Methods for the treatment of radiation or chemotherapy-induced tissue damage |
| 02/12/2013 | US8372388 Method for preparing a stable TNF-α vaccine |
| 02/12/2013 | CA2648313C Calcium phosphate complex in acid containing chewing gum |
| 02/12/2013 | CA2567827C Pharmaceutical compositions comprising polyethylene glycol having a molecular weight of less than 600 daltons |
| 02/12/2013 | CA2535013C Micro-particle fatty acid salt solid dosage formulations for therapeutic agents |
| 02/12/2013 | CA2493471C Compounds binding to p-selectin |
| 02/12/2013 | CA2475310C Antimicrobial streptococcus salivarius strain and use thereof for preventing dental caries |
| 02/12/2013 | CA2461740C Synthesis of cyclosporin analogs |
| 02/12/2013 | CA2419529C Diagnosis and treatment of tumor-suppressor associated disorders |
| 02/12/2013 | CA2416988C Leucine-based motif and clostridial neurotoxins |
| 02/12/2013 | CA2388450C Tadg-15: an extracellular serine protease overexpressed in carcinomas |
| 02/12/2013 | CA2382303C Methods of and compositions for inhibiting the proliferation of mammalian cells |
| 02/12/2013 | CA2359650C Pharmaceutical preparations and methods for inhibiting tumors |
| 02/12/2013 | CA2345817C Novel methods for therapeutic vaccination |
| 02/12/2013 | CA2308842C Amelioration of peyronie's disease |
| 02/12/2013 | CA2230144C Variants of vascular endothelial cell growth factor, their uses, and processes for their production |
| 02/07/2013 | WO2013020136A2 Treatment of traumatic brain injury |
| 02/07/2013 | WO2013020108A2 Bile acid recycling inhibitors for treatment of pancreatitis |
| 02/07/2013 | WO2013020079A2 Conjugates of an il-11 moiety and a polymer |
| 02/07/2013 | WO2013020074A2 A broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza hemagglutinin |
| 02/07/2013 | WO2013020064A1 Collagen 7 and related methods |
| 02/07/2013 | WO2013020060A1 Collagen mixture and method of making the same |
| 02/07/2013 | WO2013019980A1 Compositions and methods for the treatment of asthma and associated disorders |
| 02/07/2013 | WO2013019923A2 Methods for detecting progenitor cells and uses thereof |
| 02/07/2013 | WO2013019805A1 Treatment of heart failure and related conditions |
| 02/07/2013 | WO2013019745A1 Methods and compositions for genetically modifiying cells |
| 02/07/2013 | WO2013019652A1 Purified proteins |
| 02/07/2013 | WO2013019615A2 Switch costimulatory receptors |
| 02/07/2013 | WO2013019445A2 Anti-angiogenic peptides and uses thereof |
| 02/07/2013 | WO2013019222A1 Compositions and methods for treating myelodysplastic syndrome |
| 02/07/2013 | WO2013019221A1 Compositions and methods for treating myelodysplastic syndrome |
| 02/07/2013 | WO2013019220A1 Compositions and methods for treating myelodysplastic syndrome |
| 02/07/2013 | WO2013018977A1 Edar ligand-derived peptide and uses thereof |
| 02/07/2013 | WO2013018976A1 Wnt family-derived peptide and uses thereof |
| 02/07/2013 | WO2013018837A1 Left ventricular diastolic function improving agent |
| 02/07/2013 | WO2013018765A1 Pharmaceutical composition containing loxoprofen |
| 02/07/2013 | WO2013018690A1 Erap1-derived peptide and use thereof |
| 02/07/2013 | WO2013018169A1 Antimicrobial activity enhancing agent |
| 02/07/2013 | WO2013018098A2 Long-acting growth hormone and methods of producing same |
| 02/07/2013 | WO2013018091A1 Particles for the treatment of neurodegenerative diseases |
| 02/07/2013 | WO2013018035A1 Pharmaceutical composition comprising factor vii encapsulated in micelles |
| 02/07/2013 | WO2013017707A1 Process for a growth factor containing composition from platelets |
| 02/07/2013 | WO2013017672A1 Mammal sestrins in the treatment of muscle wasting |
| 02/07/2013 | WO2013017653A1 Hcv immunotherapy |
| 02/07/2013 | WO2013017650A2 Formulations containing saccharomyces boulardii and superoxide dismutase (sod) to control obesity |
| 02/07/2013 | WO2013017571A1 Aqueous solutions of lipophilic substances, in particular medicinal solutions |
| 02/07/2013 | WO2013017555A1 Factor vii compositions with specific glycosylation for controlled half-life |
| 02/07/2013 | WO2013017522A1 Alteration of proteolytic cleavage of botulinum neurotoxins |
| 02/07/2013 | WO2013017053A1 Composite vaccine for preventing and treating alzheimer's disease and preparation method therefor |
| 02/07/2013 | WO2013016896A1 Agrocybe aegerita lectin aal-2, and encoding gene thereof, preparation method therefor and application thereof |
| 02/07/2013 | WO2013016754A1 Method and formulation for inhalation |
| 02/07/2013 | WO2012169822A9 Fusion protein for suppressing cancer cell growth and suppressing vasculogenesis, and anticancer composition comprising same |
| 02/07/2013 | WO2012016186A8 Macrocyclic kinase inhibitors and uses thereof |
| 02/07/2013 | WO2011139820A8 Methods of use of soluble cd24 for therapy of rheumatoid arthritis |
| 02/07/2013 | WO2011085063A9 Immune modulators relating to foxo3a |
| 02/07/2013 | US20130036520 USE OF DIG3 INSECTICIDAL CRYSTAL PROTEIN IN COMBINATION WITH Cry1Ab FOR MANAGEMENT OF RESISTANCE IN EUROPEAN CORNBORER |
| 02/07/2013 | US20130036481 Use of perlecan domain v in treating amyloidogenic disease |
| 02/07/2013 | US20130035669 Sustained delivery of an active agent using an implantable system |
| 02/07/2013 | US20130035297 Compounds for enzyme inhibition |
| 02/07/2013 | US20130035296 Therapeutic peptides |
| 02/07/2013 | US20130035295 Use of Peptide Epoxyketones for Metastasis Suppression |
| 02/07/2013 | US20130035294 Neuromedin and FN-38 Peptides for Psychotic Diseases |
| 02/07/2013 | US20130035293 Compositions and methods for modulating dopamine neurotransmission |
| 02/07/2013 | US20130035292 NMDA Receptors Modulators and Uses Thereof |
| 02/07/2013 | US20130035291 Obtainment of bioactive products from cocoa having inhibitory activity against the pep enzyme and antioxidant and/or antineurodegenerative activity |